The Global Multiple Cancer Monoclonal Antibodies Market Size is valued at 67.21 billion in 2023 and is predicted to reach 154.24 billion by the year 2031 at a 11.19% CAGR during the forecast period for 2024-2031. Cancer monoclonal antibodies are specific antibodies with identical immune cells that are clones of a single parent cell directed to specific cellular targets. Thus, monoclonal antibodies are preciously customizable due to their ...
Report ID: 1112 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 190
The Bioelectric Medicine Market Size is valued at 24.08 Billion in 2023 and is predicted to reach 43.03 Billion by the year 2031 at a 7.72 % CAGR during the forecast period for 2024-2031. Bioelectric medicine is a branch of medicine that combines neurobiology, engineering science, and molecular medicine to create nerve stimulation technologies for monitoring biological parameters during treatment. The application of electrical impuls...
Report ID: 1379 |
Delivery: Immediate |
Published: February 2024 |
No. of Pages: 160
Small Molecule Immunomodulators Market Size is valued at USD 170.74 Bn in 2023 and is predicted to reach USD 270.77 Bn by the year 2031 at a 6.07% CAGR during the forecast period for 2024-2031. Small molecule immunomodulators are compounds with low molecular weights that influence the immune system. They can be immunosuppressants (e.g., corticosteroids, JAK inhibitors) or immunostimulants (e.g., TLR agonists). Examples include methotrexate for...
Report ID: 2307 |
Delivery: Immediate |
Published: January 2024 |
No. of Pages: 180
Pharmaceuticals